Chiusura precedente | 11,85 |
Aperto | 14,65 |
Denaro | 12,95 x 100 |
Domanda | 13,96 x 100 |
Min-Max giorno | 12,00 - 15,45 |
Intervallo di 52 settimane | 3,69 - 44,56 |
Volume | |
Media Volume | 94.353 |
Capitalizzazione | 18,769M |
Beta (mensile su 5 anni) | 2,11 |
Rapporto PE (ttm) | N/D |
EPS (ttm) | -17,96 |
Prossima data utili | 16 ago 2024 - 20 ago 2024 |
Rendimento e dividendo (futuro) | N/D (N/D) |
Data ex dividendo | 25 mar 2024 |
Stima target 1A | N/D |
TAMPA, FL, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Superlatus, Inc. (“Superlatus”), a food technology and distribution company and wholly owned subsidiary of TRxADE HEALTH, Inc. (NASDAQ: MEDS, “TRxADE”), a pharmaceutical exchange platform provider, is pleased to announce that its subsidiary, Superlatus PD Holding Company, has entered into a supplier agreement with Rainforest Distribution Corp. (“Rainforest”), a leading Consumer Packaged Goods distributor serving over 3,000 retailers across 15 states i
Spero is another addition to the growing Superlatus CPG portfolio under their Urgent Company umbrella of brands.Spero® is a plant-based tech company specializing in alternative dairy and egg replacements, on a mission to outcompete traditional dairy and egg products in scale, price, taste, and nutrition by utilizing internationally patent-pending technologies that transforms low-cost, sustainable, and scalable ingredients into plant-based alternatives. Spero’s mission is to scale mainstream dair
TAMPA, FL, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Superlatus, Inc., a food technology and distribution company that recently merged with a subsidiary of pharmaceutical exchange platform provider TRxADE HEALTH, Inc. (Nasdaq: MEDS), today announced it plans to enter the worldwide pet foods market, specializing in plant-based, high-protein foods and snacks. Superlatus will launch the expansion with assorted flavors of baked plant-based treats, then intends to follow with a full offering of veterinarian